↓ Skip to main content

HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study

Overview of attention for article published in British Medical Journal, August 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
11 news outlets
twitter
152 X users
facebook
7 Facebook pages

Citations

dimensions_citation
118 Dimensions

Readers on

mendeley
204 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study
Published in
British Medical Journal, August 2019
DOI 10.1136/bmj.l4894
Pubmed ID
Authors

Marcus Lind, Aldina Pivodic, Ann-Marie Svensson, Arndis F Ólafsdóttir, Hans Wedel, Johnny Ludvigsson

X Demographics

X Demographics

The data shown below were collected from the profiles of 152 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 204 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 204 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 25 12%
Other 19 9%
Researcher 17 8%
Student > Ph. D. Student 17 8%
Student > Bachelor 14 7%
Other 38 19%
Unknown 74 36%
Readers by discipline Count As %
Medicine and Dentistry 72 35%
Nursing and Health Professions 17 8%
Biochemistry, Genetics and Molecular Biology 8 4%
Engineering 4 2%
Pharmacology, Toxicology and Pharmaceutical Science 3 1%
Other 19 9%
Unknown 81 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 165. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 May 2020.
All research outputs
#251,504
of 25,732,188 outputs
Outputs from British Medical Journal
#3,269
of 64,992 outputs
Outputs of similar age
#4,895
of 350,831 outputs
Outputs of similar age from British Medical Journal
#75
of 740 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 64,992 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 45.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,831 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 740 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.